We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · February 13, 2014

Hypoxia-Driven Gene Expression Is Prognostic in Stage II/III Colon Cancer

Clinical Cancer Research


Additional Info

Clinical Cancer Research
Hypoxia Driven Gene Expression Is an Independent Prognostic Factor in Stage II and III Colon Cancer Patients
Clin. Cancer Res 2014 Jan 31;[EPub Ahead of Print], J Dekervel, D Hompes, H van Malenstein, D Popovic, X Sagaert, B De Moor, E Van Cutsem, A D'hoore, C Verslype, J van Pelt

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading